Shanghai Changzheng Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1955-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.shczyy.com
a Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell Leukemia
Early Phase 1
Recruiting
- Conditions
- Relapsed/Refractory Multiple MyelomaRelapsed/Refractory Plasma Cell Leukemia
- Interventions
- Drug: CAR-T cells Infusion
- First Posted Date
- 2024-12-05
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 24
- Registration Number
- NCT06718270
- Locations
- 🇨🇳
Shanghai Changzheng Hospital, Shanghai, Shanghai, China
Carvedilol and Alverine in Portal Hypertension
- First Posted Date
- 2024-11-20
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06696248
Efficacy and Safety of LC-Z300-01 on Proteinuria in Diabetic Patients
Not Applicable
Not yet recruiting
- Conditions
- Diabetic Kidney Disease
- First Posted Date
- 2024-11-13
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT06686758
- Locations
- 🇨🇳
Shanghai Changzheng Hospital, Shanghai, Shanghai, China
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α SrRNA in Treating Metastatic CRC Patients
- First Posted Date
- 2024-10-01
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 9
- Registration Number
- NCT06621173
- Locations
- 🇨🇳
Shanghai Changzheng Hospital，Naval Medical University, Shanghai, Shanghai, China
The Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis Analysis
Recruiting
- Conditions
- Healthy PeopleBenign Prostatic HyperplasiaProstate Cancer
- Interventions
- Diagnostic Test: Prostatic or Pelvic MRDiagnostic Test: Prostatic Biopsy
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT06589154
- Locations
- 🇨🇳
Shanghai Changzheng Hospital, Shanghai, Shanghai, China
Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells
Early Phase 1
Recruiting
- Conditions
- Renal Cell Carcinoma
- Interventions
- Biological: anti-CD70-CAR-T cells
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 9
- Registration Number
- NCT06586658
- Locations
- 🇨🇳
Changzheng hospital, Shanghai, Shanghai, China
Irinotecan Hydrochloride Liposome Injection (Ⅱ) Combined with Fluorouracil, Folinic Acid, Vermofenib and Cetuximab in First-line Treatment of BRAFV600E Mutated Advanced Colorectal Cancer
Phase 2
Recruiting
- Conditions
- Colorectal Carcinoma
- Interventions
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-09-19
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 75
- Registration Number
- NCT06603376
- Locations
- 🇨🇳
Shanghai Changzheng Hospital, Shanghai, China
Endocrine and Exocrine Secretory Function Alterations After Moderately Severe and Severe Acute Pancreatitis
Active, not recruiting
- Conditions
- Acute Pancreatitis (AP)Diabetes Mellitus
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT06590935
- Locations
- 🇨🇳
Shanghai Changzheng Hospital, Shanghai, Shanghai, China
Establishment of Multiparametric Prediction Models for Moderate to SevereThyroid Associated Ophthalmopathy
Not yet recruiting
- Conditions
- Thyroid Associated Ophthalmopathy
- First Posted Date
- 2024-09-10
- Last Posted Date
- 2024-09-10
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 150
- Registration Number
- NCT06590220
Hyperglycemia and Acute Pancreatitis
Completed
- Conditions
- Acute Pancreatitis (AP)Diabetes Mellitus
- First Posted Date
- 2024-09-10
- Last Posted Date
- 2024-09-19
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 4500
- Registration Number
- NCT06590233
© Copyright 2025. All Rights Reserved by MedPath